pertussis
pertussis
Explore linked clinical trials. Standard reference: MONDO:000507717 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Clostridium infectious disease, Corynebacterium Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, diphtheria, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 / Phase 3 | 2026-09-03 | NCT06947499 | |
| Study of BK1803 in Healthy Infants | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Clostridium infectious disease, Corynebacterium Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, diphtheria, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 3 | 2026-08-28 | NCT07793513 | |
| A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined Vaccine | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanus | Not yet recruiting | Not stated | 2026-08-04 | NCT07744347 | |
| Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, Vaccine-Preventable Diseases, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanus | Not yet recruiting | Phase 4 | 2026-06-02 | NCT07621341 | |
| A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human Infection | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, bordetellosis, gram-negative bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder | Active, not recruiting | Phase 4 | 2026-05-07 | NCT06903221 | |
| CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools | Bacterial Infections and Mycoses, COVID-19, Coronaviridae Infections, Infections, Mononegavirales infectious disease, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, bacterial infectious disease, bordetellosis, gram-negative bacterial infections, influenza, lung disorder, pertussis, pneumonia, respiratory syncytial virus infectious disease, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-05-01 | NCT06640387 | |
| Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, bordetellosis, gram-negative bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder | Active, not recruiting | Not stated | 2026-04-06 | NCT06258057 | |
| A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanus | Not yet recruiting | Phase 1 | 2026-03-25 | NCT07492303 | |
| Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanus | Not yet recruiting | Phase 1 / Phase 2 | 2026-02-18 | NCT07418372 | |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective | Adenophorea Infections, Alphavirus infectious disease, Arenaviridae infectious disease, Bacterial Infections and Mycoses, Bunyaviridae infectious disease, Caliciviridae infectious disease, Clostridium infectious disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Encephalitis, Arbovirus, Encephalitis, Viral, Enoplea infectious disease, Epstein-Barr virus infection, Euglenozoa Infections, Flaviviridae infectious disease, Flavivirus Infections, Genital Diseases, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Infections, Arenavirus, Japanese encephalitis, Mononegavirales infectious disease, Mosquito-Borne Diseases, Mycoplasma Infections, Mycoplasmatales Infections, Neglected Diseases, Nematoda infectious disease, Neuroinflammatory Diseases, Nipah Virus Infection, Norovirus Infections, Paramyxoviridae infectious disease, Parvoviridae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, Q fever, RNA Virus Infections, Reoviridae infectious disease, Rift valley fever, Rotavirus infection, Rubivirus Infections, Secernentea Infections, Severe Fever with Thrombocytopenia Syndrome, Skin and Connective Tissue Diseases, Spirurida Infections, Stomatognathic Diseases, Togaviridae infectious disease, Trematode Infections, Tumor Virus Infections, Urogenital Diseases, Vaccine-Preventable Diseases, Varicella Zoster Virus Infection, Zika virus infectious disease, Zoonoses, adenoviridae infectious disease, arbovirus infection, bacterial infectious disease, bacterial sexually transmitted disease, bordetellosis, brain disorder, brucellosis, burkholderia infectious disease, central nervous system disorder, central nervous system infectious disorder, chickenpox, chikungunya, chlamydia infectious disease, chlamydiaceae infections, dengue disease, digestive system disorder, encephalitis, enterovirus infectious disease, filarial elephantiasis, filariasis, giardiasis, gram-negative bacterial infections, gram-positive bacterial infections, hantavirus infectious disease, helminthiasis, henipavirus infectious disease, hepatitis, hepatitis A virus infection, hepatitis E virus infection, hepatitis, non-human animal, hepatitis, viral, animal, infectious disease, infectious encephalitis, intestinal disorder, leishmaniasis, leptospirosis, liver disorder, lymphatic system disorder, lymphedema, malaria, measles, melioidosis, meningitis, morbillivirus infectious disease, mouth disorder, mumps infectious disease, nervous system disorder, non-human animal disease, parasitic infectious disease, parasitic intestinal disorder, parasitic skin disorder, parotid disorder, parotitis, pertussis, protozoa infectious disease, respiratory system disorder, respiratory tract infectious disorder, rubella, salivary gland disorder, schistosomiasis, sexually transmitted disease, skin disorder, skin disorder caused by infection, spirochaetales infections, tetanus, tick-borne encephalitis, tick-borne infectious disease, trichuriasis, vector-borne disease, viral hemorrhagic fever, viral hepatitis, viral infection of central nervous system, viral infectious disease, yellow fever | Recruiting | Not stated | 2026-01-22 | NCT07358910 | |
| Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, bordetellosis, gram-negative bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 1 | 2025-12-04 | NCT06827470 | |
| Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, bordetellosis, gram-negative bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder | Active, not recruiting | Not stated | 2025-10-03 | NCT06888076 | |
| A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanus | Active, not recruiting | Phase 3 | 2025-09-15 | NCT05091619 | |
| Study of Concomitant Administration of the sIPV and DTaP or MMR | Bacterial Infections and Mycoses, Clostridium infectious disease, Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral infectious disease | Not yet recruiting | Phase 4 | 2025-04-17 | NCT06920069 | |
| Impact of Bacterial Expression and Immune Response in the Severity of Pertussis | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, bordetellosis, gram-negative bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not applicable | 2024-05-24 | NCT05897879 | |
| Pediatric Pertussis in Ambulatory Settings | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, bordetellosis, gram-negative bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2024-02-08 | NCT04807712 | |
| Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanus | Recruiting | Phase 1 | 2024-01-03 | NCT06184542 |